Marc Peeters

Oncology Department, Antwerp University Hospital (UZA)

Affiliated withAntwerp University Hospital (UZA)Antwerp University University of Antwerp

Research Area

Biography

Marc Peeters has not added Biography.
If you are Marc Peeters and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 59	2016
Publication title Cited by 14	2022

Other Publications

Article	Year
Imatinib for the treatment of patients with unresectable or metastatic malignant KIT-positive gastrointestinal stromal tumours: an open-label Belgian trial. Acta gastro-enterologica Belgica\| PubMed ID: 17343077	2006
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 17470858	2007
Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis. Annals of surgical oncology\| PubMed ID: 17960463	2008
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18316791	2008
Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging... Acta gastro-enterologica Belgica\| PubMed ID: 18330088	2007
Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 18707864	2008
Unusual serum electrophoresis pattern in a woman with pancreatic carcinoma. Clinical chemistry\| PubMed ID: 18755907	2008
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18794099	2008
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival. Cancer investigation\| PubMed ID: 18853313	2008
Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today? The oncologist\| PubMed ID: 19144681	2009
Vandetanib with FOLFIRI in patients with advanced colorectal adenocarcinoma: results from an open-label, multicentre Phase I study. Cancer chemotherapy and pharmacology\| PubMed ID: 19184020	2009
Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy. Cancer\| PubMed ID: 19189371	2009
Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19318496	2009
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study. BMC cancer\| PubMed ID: 19366444	2009
Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and ... Oncology reports\| PubMed ID: 19513511	2009
Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma. Histology and histopathology\| PubMed ID: 19554504	2009
Forcing cancer cells to commit suicide. Cancer biotherapy & radiopharmaceuticals\| PubMed ID: 19694574	2009
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19738126	2009
Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis. Cancer biotherapy & radiopharmaceuticals\| PubMed ID: 19877886	2009
Cardiovascular risk status can influence the colorectal cancer screening strategy. Digestion\| PubMed ID: 20029205	2010
Psychometric evaluation of the FACT Colorectal Cancer Symptom Index (FCSI-9): reliability, validity, responsiveness, and clinical meaningfulness. The oncologist\| PubMed ID: 20189976	2010
Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas. BMC cancer\| PubMed ID: 20459770	2010
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20567019	2010
Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma. Cancer\| PubMed ID: 20669326	2010
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20837948	2010
Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation. Future oncology (London, England)\| PubMed ID: 20919831	2010
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal ... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20921462	2010
In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells. Nuclear medicine and biology\| PubMed ID: 21055628	2010
The presence of Y chromosomal deoxyribonucleic acid in the female vaginal swab: possible implications for human papillomavirus testing. Cancer epidemiology\| PubMed ID: 21095173	2011
MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option? Virchows Archiv : an international journal of pathology\| PubMed ID: 21113617	2011
Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadoli... Radiation research\| PubMed ID: 21175342	2011
Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab. International journal of colorectal disease\| PubMed ID: 21190026	2011
EGFR in melanoma: clinical significance and potential therapeutic target. Journal of cutaneous pathology\| PubMed ID: 21352258	2011
Retention of the in vitro radiosensitizing potential of gemcitabine under anoxic conditions, in p53 wild-type and p53-deficient non-small-cell lung carcinoma cells. International journal of radiation oncology, biology, physics\| PubMed ID: 21377279	2011
In vivo imaging of apoptosis in oncology: an update. Molecular imaging\| PubMed ID: 21521554	2011
Digestive oncologist in the gastroenterology training curriculum. World journal of gastroenterology\| PubMed ID: 21556128	2011
Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights. Magma (New York, N.Y.)\| PubMed ID: 21567161	2011
Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI. Cancer microenvironment : official journal of the International Cancer Microenvironment Society\| PubMed ID: 21618031	2011
Biologic therapies in the metastatic colorectal cancer treatment continuum--applying current evidence to clinical practice. Cancer treatment reviews\| PubMed ID: 21899955	2012
Panitumumab in combination with cytotoxic chemotherapy for the treatment of metastatic colorectal carcinoma. Clinical colorectal cancer\| PubMed ID: 21925954	2012
(99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab. Journal of nuclear medicine : official publication, Society of Nuclear Medicine\| PubMed ID: 22045708	2011
Expression analysis on archival material: comparison of 5 commercially available RNA isolation kits for FFPE material. Diagnostic molecular pathology : the American journal of surgical pathology, part B\| PubMed ID: 22089347	2011
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase... Lancet (London, England)\| PubMed ID: 22119496	2011
Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clinical & developmental immunology\| PubMed ID: 22162712	2011
The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Bel... Annals of surgical oncology\| PubMed ID: 22395983	2012
Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft mo... Molecular imaging\| PubMed ID: 22469241	2012
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II tria... BMC cancer\| PubMed ID: 22494623	2012
Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Annals of surgical oncology\| PubMed ID: 22526897	2012
Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)\| PubMed ID: 22706167	2013
Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 22753904	2012
Will the medical student in the team please stand up? The Lancet. Oncology\| PubMed ID: 22846828	2012
The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors. Current pharmaceutical design\| PubMed ID: 22973959	2013
Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PloS one\| PubMed ID: 23094027	2012
Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members. BMC cancer\| PubMed ID: 23148666	2012
Mutant KRAS codon 12 and 13 alleles in patients with metastatic colorectal cancer: assessment as prognostic and predictive biomarkers of response to panitumumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 23182985	2013
Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23325582	2013
Expression analysis on archival material revisited: isolation and quantification of RNA extracted from FFPE samples. Diagnostic molecular pathology : the American journal of surgical pathology, part B\| PubMed ID: 23370428	2013
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) mul... BMC cancer\| PubMed ID: 23587148	2013
An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastati... Targeted oncology\| PubMed ID: 23625191	2013
Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance. The oncologist\| PubMed ID: 23821327	2013
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting. Expert opinion on therapeutic targets\| PubMed ID: 23848525	2013
Antineoplastic therapy-induced pulmonary toxicity. Expert review of anticancer therapy\| PubMed ID: 23984900	2013
How to find the Ariadne's thread in the labyrinth of salvage treatment options for metastatic colorectal cancer? Expert opinion on biological therapy\| PubMed ID: 24673103	2014
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority pha... The Lancet. Oncology\| PubMed ID: 24739896	2014
Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response. BMC research notes\| PubMed ID: 24899223	2014
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors. Cancer treatment reviews\| PubMed ID: 24953979	2014
The role of targeted therapy for gastrointestinal tumors. Expert review of gastroenterology & hepatology\| PubMed ID: 24957206	2014
ASPECCT: panitumumab versus cetuximab for colorectal cancer--authors' reply. The Lancet. Oncology\| PubMed ID: 24988928	2014
Use of antiemetics in the prevention of chemotherapy-induced nausea and vomiting: review and focus on the Belgian situation. Acta gastro-enterologica Belgica\| PubMed ID: 25090823	2014
The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein. BMC cancer\| PubMed ID: 25128202	2014
Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins. Cancer letters\| PubMed ID: 25192874	2014
Liquid biopsies in lung cancer: the new ambrosia of researchers. Biochimica et biophysica acta\| PubMed ID: 25444714	2014
Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer. Cancer letters\| PubMed ID: 25449778	2015
FOLFIRI with cetuximab or bevacizumab: FIRE-3. The Lancet. Oncology\| PubMed ID: 25456374	2014
Case histories in unresectable liver-dominant metastatic colorectal cancer. Future oncology (London, England)\| PubMed ID: 25478766	2014
Cancer and the microbiome: potential applications as new tumor biomarker. Expert review of anticancer therapy\| PubMed ID: 25495037	2015
Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast ca... Oncoscience\| PubMed ID: 25593984	2014
Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1. Journal of molecular endocrinology\| PubMed ID: 25612765	2015
Incorporating anti-VEGF pathway therapy as a continuum of care in metastatic colorectal cancer. Current treatment options in oncology\| PubMed ID: 25813037	2015
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions. Cancer immunology, immunotherapy : CII\| PubMed ID: 25863943	2015
Erratum: preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Onco... BMC cancer\| PubMed ID: 25879441	2015
Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status. Drugs\| PubMed ID: 25895463	2015
Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancer. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 25956209	2015
Randomized trial of TAS-102 for refractory metastatic colorectal cancer. The New England journal of medicine\| PubMed ID: 25970050	2015
The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines. BMC research notes\| PubMed ID: 26032726	2015
Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 26049686	2015
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward. Gastroenterology research and practice\| PubMed ID: 26101524	2015
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer. Oncotarget\| PubMed ID: 26125230	2015
Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor. American journal of cancer research\| PubMed ID: 26269754	2015
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS? Oncotarget\| PubMed ID: 26318427	2015
Study protocol for a randomized controlled trial: tongue strengthening exercises in head and neck cancer patients, does exercise load matter? Trials\| PubMed ID: 26340887	2015
Next generation exome sequencing of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1 reveals different lineages. Cancer genetics\| PubMed ID: 26341699	2015
Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 26341920	2015
Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2. Drugs\| PubMed ID: 26347132	2015
A phase I study of volasertib combined with afatinib, in advanced solid tumors. Cancer chemotherapy and pharmacology\| PubMed ID: 26349473	2015
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer. PloS one\| PubMed ID: 26421426	2015
Entrectinib: a potent new TRK, ROS1, and ALK inhibitor. Expert opinion on investigational drugs\| PubMed ID: 26457764	2015
Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis. The oncologist\| PubMed ID: 26712958	2016
Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept. Minerva chirurgica\| PubMed ID: 26771252	2016
Reducing Compounds Equivocally Influence Oxidation during Digestion of a High-Fat Beef Product, which Promotes Cytotoxicity in Colorectal Carcinoma Cell Lines. Journal of agricultural and food chemistry\| PubMed ID: 26836477	2016
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patient... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 26903575	2016
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice. Oncotarget\| PubMed ID: 26919248	2016
APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines. Cancer letters\| PubMed ID: 26975633	2016
Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors. British journal of cancer\| PubMed ID: 26978006	2016
Evaluation and consequences of heterogeneity in the circulating tumor cell compartment. Oncotarget\| PubMed ID: 26980749	2016
Feasibility of an interactive electronic self-report tool for oral cancer therapy in an outpatient setting. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 27025594	2016
Targeting Angiogenesis in Biliary Tract Cancers: An Open Option. International journal of molecular sciences\| PubMed ID: 28212293	2017
Validity and Reproducibility of a Food Frequency Questionnaire for Dietary Factors Related to Colorectal Cancer. Nutrients\| PubMed ID: 29149033	2017
The predictive value of primary tumor location in patients with metastatic colorectal cancer: A systematic review. Critical reviews in oncology/hematology\| PubMed ID: 29279095	2018
Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients. Clinical colorectal cancer\| PubMed ID: 29605591	2018
Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutation... Clinical colorectal cancer\| PubMed ID: 29627309	2018
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress. Cancers\| PubMed ID: 29690507	2018
Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line pani... British journal of cancer\| PubMed ID: 30013091	2018
Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib. Cancers\| PubMed ID: 30650638	2019
Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol. Cancers\| PubMed ID: 30935089	2019
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review. International journal of molecular sciences\| PubMed ID: 31052546	2019
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells. Cancers\| PubMed ID: 31635070	2019
Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform. ESMO open\| PubMed ID: 32571785	2020
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment. ESMO open\| PubMed ID: 34597941	2021
Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. Pharmacology & therapeutics\| PubMed ID: 34999181	2022
Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients. ESMO open\| PubMed ID: 35305399	2022
Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report. Journal of medical case reports\| PubMed ID: 35831829	2022
Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review. Journal of bone oncology\| PubMed ID: 35860387	2022
Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care Therapy. Cancers\| PubMed ID: 36077610	2022
Prognostic implications of cellular senescence in resected non-small cell lung cancer. Translational lung cancer research\| PubMed ID: 36090630	2022
Increasing Adherence to Prophylactic Swallowing Exercises During Head and Neck Radiotherapy: The Multicenter, Randomized Controlled PRESTO-Trial. Dysphagia\| PubMed ID: 36121560	2022
The prognostic impact of the immune signature in head and neck squamous cell carcinoma. Frontiers in immunology\| PubMed ID: 36268020	2022
Point scintillator dosimetry in ultra-high dose rate electron "FLASH" radiation therapy: A first characterization. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)\| PubMed ID: 36302279	2022
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 36341493	2022
Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 36427394	2023
Boosting capacity of a fourth dose BNT162b2 in cancer patients. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 36521333	2022